Fount Bio

Health Care · Biotechnology

Overview

Fount Bio is developing innovative biopolymer-based products leveraging bioorthogonal chemistry to overcome challenges to hyaluronic acid delivery and retention.

Funding and backers

Total raised
$8.2M
1 round on record
Latest round
$8.2M
Venture round · Jul 2021 · 5 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
64 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1, 2021 Raised a round Venture round $8.2M · SEC Form D 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2021 $8.2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Fount Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Douglas LevinsonExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
High-Tech Gründerfonds
backs Draupnir Bio
Bayern Kapital
backs T-Curx
Canaan Partners
backs Archipelago
Entrepreneurs Roundtable Accelerator
backs Caire Beauty
Inkef
backs Draupnir Bio
i&i Bio
backs T-Curx
Similar startupsby what they do, their industry and backers
ArchipelagoFounded 2018 · 51-200 employees · 3 roles
Archipelago helps you overcome challenges you experience in working with traditional spreadsheet property schedules.
Optimeos501-1000 employees
About the technology. Optimeos is developing a solution suite to overcome crucial formulation challenges and address unmet medical needs.
T-CurxVenture round · 6 mo ago · Founded 2017
T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges…
Caire Beauty
Best skincare for mature, menopause and 40+ skin. Caire’s clean, clinically tested formulas with hyaluronic acid and collagen-building…
VictrexVenture round · 1 mo ago · 201-500 employees
Victrex is a world leader in PEEK and PAEK-based polymer solutions, helping customers to overcome complex design and engineering challenges.
Alveron PharmaSeed $5.4M · 23 mo ago · 11-50 employees
Alveron Pharma is developing a unique coagulationplatform technology with the world.

Visa sponsorship

United StatesUS 0
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Fount Bio, Inc., Cambridge, MA
Other sponsors in the same field
Triple Ring Technologies 2 filingsPheast Therapeutics 2 filingsAegis Sciences Corporation 1 filingsSyntis 1 filings
Alert me
US Department of Labor · latest filing Oct 29, 2024 · Visa details by country

Financials

Total raised
$8.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2021 $8.2M Details

People

Douglas Levinson
Executive Officer, Director
SEC Form D
Samir Mitragotri
Director
SEC Form D
Anthony Aiudi
Director
SEC Form D
Justin Burns
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Cambridge United States
HQ
Somerville United States
Regional office
Connect with Fount Bio
100 Chestnut St., Somerville, MA 02143
company site